• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Med J Islam Repub Iran . Predictors of death in patients with COVID-19: A cross-sectional study in West of Iran

tetano

Editor, Senior Moderator
Med J Islam Repub Iran


. 2021 Aug 11;35:103.
doi: 10.47176/mjiri.35.103. eCollection 2021.
Predictors of death in patients with COVID-19: A cross-sectional study in West of Iran


Manoochehr Karami[SUP] 1 2 [/SUP], Mohammad Mirzaei[SUP] 3 [/SUP], Fatemeh Shahbazi[SUP] 1 4 [/SUP], Fariba Keramat[SUP] 5 [/SUP], Ebrahim Jalili[SUP] 6 [/SUP], Saeid Bashirian[SUP] 7 [/SUP], Rashid Heidarimoghadam[SUP] 8 [/SUP], Jalal Bathaei[SUP] 3 [/SUP], Salman Khazaei[SUP] 9 10 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) is a contagious disease caused by a newly identified coronavirus. Our knowledge about the survival rate and prognostic factors of the disease is not established well. The purpose of this study was to evaluate the predictors of COVID-19 mortality in Hamadan province in western Iran. Methods: In this study, we included all laboratory-confirmed COVID-19 cases with known treatment outcomes in Hamadan province, Iran, between 20, 2020, to May 10, 2020. Demographic, clinical, laboratory data, and treatment outcomes were obtained from computerized medical records and compared between survived cases and patients with death outcomes. Univariable and multivariable logistic regression models were used to determine the predictors of death. Results: From 749 investigated patients, 77 patients (10.28%) died during the treatment. The Mean age of patients was 53.97±19.04 years. Multivariable logistic regression showed that males had 2.07 (95% CI: 1.73, 2.54) fold higher odds of death. Those with 60 years old and more had 6.49 (95% CI: 4.53, 7.93) fold higher odds of death. Patients with an underlying disease had 7.14 (95% CI: 6.94, 7.38) fold higher odds of death, and patients who were hospitalized in the ICU ward had 2.24 (95% CI: 1.75, 2.90) times higher odds of COVID-19 related mortality. Conclusion: The potential predictors of death in COVID-19 cases, including the male gender, older age, and having an underlying disease could help physicians to identify patients with poor prognoses at an early stage and better management of them.

Keywords: COVID-19; Coronavirus; Epidemiology; Iran; Mortality.
 
Back
Top Bottom